Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | DPP4 | P27487 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16816913 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL17982719 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL10535250 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL8229978 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL4728748 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL4086543 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL210030 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL8528068 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL443815 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| Hydrochloric Acid SCHEMBL6946154 | 0.98 | ALDH1A1 (0.57) | LMNANR1I2PTGS1ADRA1ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-20250296959-A1 | B7-H3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-09-25 | — | — | US | claimed |
| WO-2024190663-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| CN-118561726-A | Method for preparing 3-phenyl-L-serine or derivative thereof and ethyl ester thereof | 苏州引航生物科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118530962-A | Modified threonine transaldolase and application thereof | 苏州引航生物科技有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-114540335-B | Immobilized modified threonine transaldolase and application thereof | 湖南引航生物科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-113583989-B | Modified threonine transaldolase and application thereof | 苏州引航生物科技有限公司 | 2024-06-25 | — | — | CN | claimed |
| US-20240026396-A1 | METHOD FOR PRODUCING TERTIARY BETA-HYDROXY-ALPHA-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2024-01-25 | — | — | US | claimed |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2023-04-13 | — | — | US | claimed |
| CN-115819299-A | Method for preparing 3-phenyl-L-serine or derivative and ethyl ester thereof | 苏州引航生物科技有限公司 | 2023-03-21 | — | — | CN | claimed |
| EP-0115345-B1 | PROCESS FOR THE RESOLUTION OF RACEMIC OPTICALLY ACTIVE BICYCLIC IMINO-ALPHA-CARBOXYLIC ACID ESTERS AND USE OF THE COMPOUNDS OBTAINABLE IN THIS WAY FOR THE SYNTHESIS OF CARBOXYALKYL DIPEPTIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-01-07 | — | — | EP | claimed |
| US-4710583-A | ENZYMATIC COUPLING OF PHENYLSERINE WITH ASPARTIC ACID; HYDROGENATION | W. R. GRACE & CO. (US) | 1987-12-01 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| EP-0220923-A2 | Dipeptides and process | W.R. Grace & Co.-Conn. (US) | 1987-05-06 | — | — | EP | claimed |
| EP-0164389-B1 | PREPARATION OF PHENYL ALANINES BY HYDROGENATION OF PHENYL SERINES | ALKALOIDA VEGYéSZETI GYáR (HU) | 1987-04-01 | — | — | EP | claimed |
| US-4605759-A | ACIDIFYING THE REACTION PRODUCT OF GLYCINE, A BENZALDEHYDE AND GROUP 1 METAL HYDROXIDE USING WATER/SOLVENT MIXTURE AND A PHASE TRANSFER AGENT | MITSUI TOATSU CHEMICALS, INC. (JP) | 1986-08-12 | — | — | US | claimed |
| EP-0164389-A1 | PREPARATION OF PHENYL ALANINES BY HYDROGENATION OF PHENYL SERINES. | ALKALOIDA VEGYESZETI GYAR (HU) | 1985-12-18 | — | — | EP | claimed |
| WO-1985002609-A1 | PREPARATION OF PHENYL ALANINES BY HYDROGENATION OF PHENYL SERINES | ALKALOIDA VEGYÉSZETI GYÁR (HU) | 1985-06-20 | — | — | WO | claimed |
| US-4407952-A | OF GENETICALLY ENGINEERED ESCHERICHIA | AJINOMOTO COMPANY INCORPORATED (JP) | 1983-10-04 | — | — | US | claimed |
| US-3930948-A | ENZYMATIC METHOD FOR PRODUCING AROMATIC ETHYLAMINES | AJINOMOTO CO., INC. (JA) | 1976-01-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296959-A1 | B7-H3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | CD274, CD44, CD74 | LMNA 3408/4885NR1I2 4578/4885PTGS1 4251/4885 |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | TST, ABAT, AADAC | LMNA 4387/4885NR1I2 4392/4885PTGS1 4428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.